DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Modjarrad K, Roberts CC, Mills KT. et al.
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.
Lancet Infect Dis 2019;
19 (09) 1013-1022
We do not assume any responsibility for the contents of the web pages of other providers.